Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for AC Immune (ACIU) over the last 12 years, with Q3 2025 value amounting to $457527.2.

  • AC Immune's Interest & Investment Income fell 5778.49% to $457527.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year decrease of 542.45%. This contributed to the annual value of $3.6 million for FY2024, which is 20997.74% up from last year.
  • Latest data reveals that AC Immune reported Interest & Investment Income of $457527.2 as of Q3 2025, which was down 5778.49% from $553213.8 recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Interest & Investment Income peaked at $12.4 million during Q4 2021, and registered a low of -$435044.7 during Q2 2022.
  • Its 5-year average for Interest & Investment Income is $1.4 million, with a median of $457527.2 in 2025.
  • In the last 5 years, AC Immune's Interest & Investment Income surged by 597569.1% in 2021 and then tumbled by 9976.36% in 2022.
  • AC Immune's Interest & Investment Income (Quarter) stood at $12.4 million in 2021, then plummeted by 99.51% to $60205.3 in 2022, then skyrocketed by 444.9% to $328060.2 in 2023, then surged by 209.34% to $1.0 million in 2024, then crashed by 54.92% to $457527.2 in 2025.
  • Its last three reported values are $457527.2 in Q3 2025, $553213.8 for Q2 2025, and $764116.1 during Q1 2025.